South Bay and Central Valley Chapter

  FDA Clears a New Artificial Pancreas System The U.S. Food and Drug Administration (FDA) cleared the iLet® Insulin-Only Bionic…

Each year at the Hope Gala, Breakthrough T1D presents the Impact Award to individuals or organizations who have demonstrated exceptional…

This spring, Breakthrough T1D Game2Give is celebrating our community of creators with the inaugural Creators for Cures event. From May…

  Breakthrough T1D Collaboration Leads to Next-Generation Cell Therapy Research  JDRF is committed to supporting the development of cell replacement therapies that…

Breakthrough T1D Northern California Advocates to be Honored at 2023 Tee to Table Event We’re excited to honor all Breakthrough…

New Clinical Trial Finds Varapamil Slows T1D Progression in Newly Diagnosed Youth A new Breakthrough T1D-funded clinical trial suggests a…

FDA Authorizes Tidepool Loop, an Automated Insulin Dosing App Last month, the U.S. Food & Drug Administration (FDA) authorized the…

On Sunday, February 26, Breakthrough T1D’s fourth annual livestream relay — newly named the Raid for Research — is happening…

Join us for the 2023 TypeOneNation Summit Our community is invited to the JDRF NorCal TypeOneNation (TON) Summit on March 25 at the…

Join us for the Breakthrough T1D NorCal Annual Meeting & Research Discussion on February 28 Save the date! On February…